Form D — Centile Bioscience Inc.
0002129392-26-000001 · filed 2026-04-16
Offering
- Industry
- Other Technology
- Exemptions
- 06b
- Total offering
- $4,054,996
- Total sold
- $3,054,996
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Centile Bioscience Inc.
- CIK
- 2129392
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 5023 WISSIOMING RD.
BETHESDA, MD 20816 - Phone
- 240-204-0747
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jakob Seidlitz · Executive OfficerBethesda, MD Find on LinkedIn ↗
-
Richard Bethlehem · Executive OfficerBethesda, MD Find on LinkedIn ↗
-
Joshua Bernstock · Executive OfficerBethesda, MD Find on LinkedIn ↗
-
L. Keith Mullins · DirectorBethesda, MD Find on LinkedIn ↗
-
Hannah Mamuszka · DirectorBethesda, MD Find on LinkedIn ↗
View original on SEC EDGAR.